Back to Journals » Clinical and Experimental Gastroenterology » Volume 3

Imatinib as the first and only treatment in Europe for adult patients at significant risk of relapse following gastrointestinal stromal tumor removal

Total article views   HTML views PDF downloads Totals
5,979 Dovepress* 5,979+ 2,152 8,131
Totals 5,979 2,152 8,131
*Since 12 May 2010
+Since July 2016

View citations on Google Scholar